SEAGEN INC

Organization

BOTHELL, WA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Drug conjugates with self-stabilizing linkers having improved physi...
- Patent number 11,944,689
- Issue date Apr 2, 2024
- SEAGEN INC.
- Philip Moquist
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cysteine mutated antibodies for conjugation
- Patent number 11,938,194
- Issue date Mar 26, 2024
- SEAGEN INC.
- Andrew Waight
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quaternized nicotinamide adenine dinucleotide salvage pathway inhib...
- Patent number 11,931,414
- Issue date Mar 19, 2024
- SEAGEN INC.
- Christopher Scott Neumann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cells with reduced surface fucosylation and methods of making and...
- Patent number 11,891,644
- Issue date Feb 6, 2024
- SEAGEN INC.
- Nicole Okeley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Hydrophobic Auristatin F compounds and conjugates thereof
- Patent number 11,857,565
- Issue date Jan 2, 2024
- SEAGEN INC.
- Svetlana O. Doronina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the preparation of pegylated drug-linkers and intermedi...
- Patent number 11,844,839
- Issue date Dec 19, 2023
- SEAGEN INC.
- Yunyu Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-AVB6 antibodies and antibody-drug conjugates
- Patent number 11,827,709
- Issue date Nov 28, 2023
- SEAGEN INC.
- Maureen Ryan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glypican 3 antibodies and conjugates thereof
- Patent number 11,819,553
- Issue date Nov 21, 2023
- SEAGEN INC.
- Travis Biechele
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating myelodysplastic syndrome and acute myeloid leuk...
- Patent number 11,820,827
- Issue date Nov 21, 2023
- SEAGEN INC.
- Shyra Gardai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Conjugates of quaternized tubulysin compounds
- Patent number 11,793,880
- Issue date Oct 24, 2023
- SEAGEN INC.
- Patrick J. Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCMA antibodies and use of same to treat cancer and immunological d...
- Patent number 11,767,365
- Issue date Sep 26, 2023
- SEAGEN INC.
- Django Sussman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of glucuronide drug-linkers and interme...
- Patent number 11,730,822
- Issue date Aug 22, 2023
- SEAGEN INC.
- Yunyu Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of HER2 positive cancers
- Patent number 11,666,572
- Issue date Jun 6, 2023
- SEAGEN INC.
- Scott Peterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective reduction of proteins
- Patent number 11,667,696
- Issue date Jun 6, 2023
- SEAGEN INC.
- Damon L. Meyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted delivery of nicotinamide adenine dinucleotide salvage path...
- Patent number 11,638,762
- Issue date May 2, 2023
- SEAGEN INC.
- Christopher Scott Neumann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
- Patent number 11,634,503
- Issue date Apr 25, 2023
- AGENSYS, INC.
- Robert Kendall Morrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD228 antibodies and antibody-drug conjugates
- Patent number 11,617,798
- Issue date Apr 4, 2023
- SEAGEN INC.
- Sharsti Sandall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the preparation of drug linker compounds
- Patent number 11,612,666
- Issue date Mar 28, 2023
- SEAGEN INC.
- Sophie Blanchard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synergistic effects between auristatin-based antibody drug conjugat...
- Patent number 11,607,460
- Issue date Mar 21, 2023
- SEAGEN INC.
- Timothy S. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycan-interacting compounds and methods of use
- Patent number RE49435
- Issue date Feb 28, 2023
- SEAGEN INC.
- Julie DeSander
Information Patent Grant
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
- Patent number 11,559,582
- Issue date Jan 24, 2023
- AGENSYS, INC.
- Daulet Satpayev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conj...
- Patent number 11,559,558
- Issue date Jan 24, 2023
- SEAGEN INC.
- Eric Sievers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-drug antibody drug conjugates
- Patent number 11,541,128
- Issue date Jan 3, 2023
- SEAGEN INC.
- Matthew R. Levengood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydrophilic antibody-drug conjugates
- Patent number 11,510,959
- Issue date Nov 29, 2022
- SEAGEN INC.
- Svetlana Doronina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycan-interacting compounds and methods of use
- Patent number 11,401,330
- Issue date Aug 2, 2022
- SEAGEN INC.
- David A. Eavarone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antibodies
- Patent number 11,401,339
- Issue date Aug 2, 2022
- SEAGEN INC.
- Julia C. Piasecki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of tubulysins and intermediates thereof
- Patent number 11,389,543
- Issue date Jul 19, 2022
- SEAGEN INC.
- Kun-Liang Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conj...
- Patent number 11,369,658
- Issue date Jun 28, 2022
- SEAGEN INC.
- Eric Sievers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Detection and treatment of CD30+ cancers
- Patent number 11,366,118
- Issue date Jun 21, 2022
- SEAGEN INC.
- Tina Albertson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-NTB-A antibodies and related compositions and methods
- Patent number 11,351,269
- Issue date Jun 7, 2022
- SEAGEN INC.
- Timothy Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES
- Publication number 20240142463
- Publication date May 2, 2024
- Seagen Inc.
- Shawna Hengel
- G01 - MEASURING TESTING
Information Patent Application
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...
- Publication number 20240139275
- Publication date May 2, 2024
- Seagen Inc.
- Eric Sievers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGAT...
- Publication number 20240131176
- Publication date Apr 25, 2024
- Seagen Inc.
- Timothy S. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF
- Publication number 20240123080
- Publication date Apr 18, 2024
- Seagen Inc.
- Philip MOQUIST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES
- Publication number 20240123079
- Publication date Apr 18, 2024
- Seagen Inc.
- Adam G. Hill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROPHILIC ANTIBODY-DRUG CONJUGATES
- Publication number 20240115648
- Publication date Apr 11, 2024
- Seagen Inc.
- Svetlana DORONINA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T CELLS WITH REDUCED SURFACE FUCOSYLATION AND METHODS OF MAKING AND...
- Publication number 20240117400
- Publication date Apr 11, 2024
- Seagen Inc.
- Nicole OKELEY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL D...
- Publication number 20240109975
- Publication date Apr 4, 2024
- Seagen Inc.
- Django Sussman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB IN C...
- Publication number 20240092936
- Publication date Mar 21, 2024
- Seagen Inc.
- Luke Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANT TARGET BINDING AGENTS AND USES THEREOF
- Publication number 20240084031
- Publication date Mar 14, 2024
- Seagen Inc.
- Paul Carter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20240076383
- Publication date Mar 7, 2024
- Seagen Inc.
- Maureen Ryan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
- Publication number 20240075134
- Publication date Mar 7, 2024
- Seagen Inc.
- Shyra Gardai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATING THE IMMUNE RESPONSE USING ANTI-CD30 ANTIBODY-DRUG CONJUG...
- Publication number 20240076394
- Publication date Mar 7, 2024
- Seagen Inc.
- Ryan A. HEISER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
- Publication number 20240076402
- Publication date Mar 7, 2024
- Seagen Inc.
- Dana KENNEDY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
- Publication number 20240075135
- Publication date Mar 7, 2024
- Seagen Inc.
- Shyra Gardai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS
- Publication number 20240042052
- Publication date Feb 8, 2024
- Seagen Inc.
- Sophie BLANCHARD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS
- Publication number 20240043556
- Publication date Feb 8, 2024
- AGENSYS, INC.
- Robert Kendall MORRISON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD228 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20240033369
- Publication date Feb 1, 2024
- Seagen Inc.
- Sharsti SANDALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-DRUG ANTIBODY DRUG CONJUGATES
- Publication number 20240033372
- Publication date Feb 1, 2024
- Seagen Inc.
- Matthew R. LEVENGOOD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER WITH A COMBINATION OF TUCATINIB AND AN A...
- Publication number 20240024320
- Publication date Jan 25, 2024
- Seagen Inc.
- Scott PETERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Cancer with Anti-TIGIT Antibodies
- Publication number 20240025998
- Publication date Jan 25, 2024
- Seagen Inc.
- Shyra Gardai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED DELIVERY OF NICOTINAMINDE ADENINE DINUCLEOTIDE SALVAGE PAT...
- Publication number 20240016953
- Publication date Jan 18, 2024
- Seagen Inc.
- Christopher Scott Neumann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycan-Interacting Compounds and Methods of Use
- Publication number 20240009306
- Publication date Jan 11, 2024
- Seagen Inc.
- Ana Paula Galvao da Silva
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glycan Analysis and Profiling
- Publication number 20240002422
- Publication date Jan 4, 2024
- Seagen Inc.
- Ana Paula Galvao da Silva
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions and Methods for Targeting Cancer Stem Cells
- Publication number 20240003889
- Publication date Jan 4, 2024
- Seagen Inc.
- David A. Eavarone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycan-Interacting Compounds and Methods of Use
- Publication number 20240000962
- Publication date Jan 4, 2024
- Seagen Inc.
- Daniel T. Dransfield
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Targeting Cancer Stem Cells
- Publication number 20240002537
- Publication date Jan 4, 2024
- Seagen Inc.
- David A. Eavarone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE REDUCTION OF PROTEINS
- Publication number 20230391848
- Publication date Dec 7, 2023
- Seagen Inc.
- Damon L. MEYER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HER2 POSITIVE CANCERS
- Publication number 20230390290
- Publication date Dec 7, 2023
- Seagen Inc.
- Scott Peterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING SOLID TUMORS DRIVEN BY HER2 ALTERATIONS WITH TU...
- Publication number 20230372342
- Publication date Nov 23, 2023
- Seagen Inc.
- Luke WALKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98473092 - VODISVA
- Serial number 98473092
- Filing date Mar 28, 2024
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98088562 - SEATTLEGENETICS
- Serial number 98088562
- Filing date Jul 17, 2023
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97766377 - SGN
- Serial number 97766377
- Registration number 7351199
- Filing date Jan 24, 2023
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97766451 - SGN
- Serial number 97766451
- Filing date Jan 24, 2023
- Seagen Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97766623 - SGEN
- Serial number 97766623
- Filing date Jan 24, 2023
- Seagen Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97387050 - TIVDAK
- Serial number 97387050
- Registration number 7179457
- Filing date Apr 28, 2022
- Seagen Inc.
- 44 - Medical services
Information Trademark
97387047
- Serial number 97387047
- Registration number 7179456
- Filing date Apr 28, 2022
- Seagen Inc.
- 44 - Medical services
Information Trademark
97326585 - LET'S TALK BLADDER CANCER
- Serial number 97326585
- Registration number 7077094
- Filing date Mar 23, 2022
- Agensys, Inc.
- 44 - Medical services
Information Trademark
97313710 - ADCETRIS
- Serial number 97313710
- Registration number 6949905
- Filing date Mar 15, 2022
- Seagen Inc.
- 44 - Medical services
Information Trademark
97171782 - CEME
- Serial number 97171782
- Registration number 7007963
- Filing date Dec 14, 2021
- Seagen Inc.
- 35 - Advertising
Information Trademark
90675409 - TIVDAQ
- Serial number 90675409
- Filing date Apr 27, 2021
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90675414 - TIVDAKT
- Serial number 90675414
- Filing date Apr 27, 2021
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90142726 - SEAGEN
- Serial number 90142726
- Registration number 6680450
- Filing date Aug 27, 2020
- SEAGEN INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90083550
- Serial number 90083550
- Registration number 6680407
- Filing date Jul 30, 2020
- SEAGEN INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88983160
- Serial number 88983160
- Registration number 6584407
- Filing date May 5, 2020
- Seattle Genetics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88983161 - TIVDAK
- Serial number 88983161
- Registration number 6598715
- Filing date Sep 25, 2018
- Seattle Genetics, Inc.
- 5 - Pharmaceutical and veterinary preparations

Organization

Patents Grantslast 30 patents

Drug conjugates with self-stabilizing linkers having improved physi...

Cysteine mutated antibodies for conjugation

Quaternized nicotinamide adenine dinucleotide salvage pathway inhib...

T cells with reduced surface fucosylation and methods of making and...

Hydrophobic Auristatin F compounds and conjugates thereof

Process for the preparation of pegylated drug-linkers and intermedi...

Anti-AVB6 antibodies and antibody-drug conjugates

Glypican 3 antibodies and conjugates thereof

Methods of treating myelodysplastic syndrome and acute myeloid leuk...

Conjugates of quaternized tubulysin compounds

BCMA antibodies and use of same to treat cancer and immunological d...

Process for the preparation of glucuronide drug-linkers and interme...

Treatment of HER2 positive cancers

Selective reduction of proteins

Targeted delivery of nicotinamide adenine dinucleotide salvage path...

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Anti-CD228 antibodies and antibody-drug conjugates

Process for the preparation of drug linker compounds

Synergistic effects between auristatin-based antibody drug conjugat...

Glycan-interacting compounds and methods of use

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conj...

Multi-drug antibody drug conjugates

Hydrophilic antibody-drug conjugates

Glycan-interacting compounds and methods of use

Anti-TIGIT antibodies

Process for the preparation of tubulysins and intermediates thereof

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conj...

Detection and treatment of CD30+ cancers

Anti-NTB-A antibodies and related compositions and methods

Patents Applicationslast 30 patents

METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...

SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGAT...

CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF

IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES

HYDROPHILIC ANTIBODY-DRUG CONJUGATES

T CELLS WITH REDUCED SURFACE FUCOSYLATION AND METHODS OF MAKING AND...

BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL D...

METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB IN C...

VARIANT TARGET BINDING AGENTS AND USES THEREOF

ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

MODULATING THE IMMUNE RESPONSE USING ANTI-CD30 ANTIBODY-DRUG CONJUG...

HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS

ANTI-CD228 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

MULTI-DRUG ANTIBODY DRUG CONJUGATES

METHODS OF TREATING CANCER WITH A COMBINATION OF TUCATINIB AND AN A...

Methods of Treating Cancer with Anti-TIGIT Antibodies

TARGETED DELIVERY OF NICOTINAMINDE ADENINE DINUCLEOTIDE SALVAGE PAT...

Glycan-Interacting Compounds and Methods of Use

Glycan Analysis and Profiling

Compositions and Methods for Targeting Cancer Stem Cells

Glycan-Interacting Compounds and Methods of Use

Compositions and Methods for Targeting Cancer Stem Cells

SELECTIVE REDUCTION OF PROTEINS

TREATMENT OF HER2 POSITIVE CANCERS

METHODS OF TREATING SOLID TUMORS DRIVEN BY HER2 ALTERATIONS WITH TU...

Trademarklast 30 trademarks

98473092 - VODISVA

98088562 - SEATTLEGENETICS

97766377 - SGN

97766451 - SGN

97766623 - SGEN

97387050 - TIVDAK

97387047

97326585 - LET'S TALK BLADDER CANCER

97313710 - ADCETRIS

97171782 - CEME

90675409 - TIVDAQ

90675414 - TIVDAKT

90142726 - SEAGEN

90083550

88983160